{"id":"https://openalex.org/W2020947579","doi":"https://doi.org/10.1161/strokeaha.108.528356","title":"Insulin-Like Growth Factor I: A Potential Neuroprotective Compound for the Treatment of Acute Ischemic Stroke?","display_name":"Insulin-Like Growth Factor I: A Potential Neuroprotective Compound for the Treatment of Acute Ischemic Stroke?","alternate_titles":[],"publication_year":2009,"publication_date":"2009-02-06","ids":{"openalex":"https://openalex.org/W2020947579","doi":"https://doi.org/10.1161/strokeaha.108.528356","mag":"2020947579","pmid":"https://pubmed.ncbi.nlm.nih.gov/19197073"},"language":"en","primary_location":{"id":"doi:10.1161/strokeaha.108.528356","doi":"https://doi.org/10.1161/strokeaha.108.528356","is_oa":false,"landing_page_url":"https://doi.org/10.1161/strokeaha.108.528356","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020947579"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072560534","display_name":"Ron Kooijman","orcid":"https://orcid.org/0000-0002-3676-477X","observed_orcids":["https://orcid.org/0000-0002-3676-477X"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ron Kooijman","raw_affiliation_strings":["From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","Ron Kooijman From the Departments of Pharmacology (FARC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","institution_ids":[]},{"raw_affiliation_string":"Ron Kooijman From the Departments of Pharmacology (FARC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102948583","display_name":"Sophie Sarre","orcid":"https://orcid.org/0000-0003-4912-1084","observed_orcids":["https://orcid.org/0000-0003-4912-1084"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sophie Sarre","raw_affiliation_strings":["From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","Sophie Sarre From the Departments of Pharmacology (FARC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","institution_ids":[]},{"raw_affiliation_string":"Sophie Sarre From the Departments of Pharmacology (FARC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111523940","display_name":"Yvette Madeleine Michotte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yvette Michotte","raw_affiliation_strings":["From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","Yvette Michotte From the Departments of Pharmacology (FARC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","institution_ids":[]},{"raw_affiliation_string":"Yvette Michotte From the Departments of Pharmacology (FARC","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053985196","display_name":"Jacques De Keyser","orcid":"https://orcid.org/0000-0002-3394-7757","observed_orcids":["https://orcid.org/0000-0002-3394-7757"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacques De Keyser","raw_affiliation_strings":["From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","Jacques De Keyser From the Departments of Pharmacology (FARC","R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pharmacology (FARC; R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC; S.S., Y.M.), and Neurology (J.D.K.), Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Jacques De Keyser From the Departments of Pharmacology (FARC","institution_ids":[]},{"raw_affiliation_string":"R.K.), Pharmaceutical Chemistry, Drug Analysis &Drug Information (FASC","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072560534"],"corresponding_institution_ids":["https://openalex.org/I13469542"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":169,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"4","first_page":"e83","last_page":"e88"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.3977000117301941,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.3977000117301941,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.37040001153945923,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.14560000598430634,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-like-growth-factor-i","display_name":"insulin-like growth factor I","score":1.0},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9559999704360962},{"id":"https://openalex.org/keywords/acute-ischemic-stroke","display_name":"acute ischemic stroke","score":0.9929999709129333},{"id":"https://openalex.org/keywords/focal-cerebral-ischemia","display_name":"focal cerebral ischemia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-binding-proteins","display_name":"IGF binding proteins","score":0.890999972820282},{"id":"https://openalex.org/keywords/apoptosis-inhibition","display_name":"apoptosis inhibition","score":0.6740000247955322},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.9729999899864197},{"id":"https://openalex.org/keywords/neurological-outcome","display_name":"neurological outcome","score":0.9559999704360962},{"id":"https://openalex.org/keywords/neural-tissue-regeneration","display_name":"neural tissue regeneration","score":0.7730000019073486},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.8299999833106995},{"id":"https://openalex.org/keywords/intranasal-administration","display_name":"intranasal administration","score":0.9639999866485596}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.947837769985199},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9174878001213074},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5913482904434204},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.5498082041740417},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.505919873714447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4758025109767914},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.4483354687690735},{"id":"https://openalex.org/C172268261","wikidata":"https://www.wikidata.org/wiki/Q4764988","display_name":"Animal studies","level":2,"score":0.4294588267803192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32952195405960083},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14947521686553955},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007334","descriptor_name":"Insulin-Like Growth Factor I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1161/strokeaha.108.528356","doi":"https://doi.org/10.1161/strokeaha.108.528356","is_oa":false,"landing_page_url":"https://doi.org/10.1161/strokeaha.108.528356","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},{"id":"pmid:19197073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19197073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"Journal Article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:53451","doi":null,"is_oa":false,"landing_page_url":"http://www.ncbi.nlm.nih.gov/sites/entrez","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W157184784","https://openalex.org/W196897566","https://openalex.org/W1529872930","https://openalex.org/W1929544011","https://openalex.org/W1964353514","https://openalex.org/W1966413777","https://openalex.org/W1968657094","https://openalex.org/W1972380138","https://openalex.org/W1980331807","https://openalex.org/W1981496258","https://openalex.org/W1990862055","https://openalex.org/W1993347684","https://openalex.org/W1994989681","https://openalex.org/W1997329894","https://openalex.org/W1998588332","https://openalex.org/W1998695769","https://openalex.org/W2001434128","https://openalex.org/W2004286315","https://openalex.org/W2007984040","https://openalex.org/W2011038554","https://openalex.org/W2012505775","https://openalex.org/W2012837633","https://openalex.org/W2015732907","https://openalex.org/W2019861549","https://openalex.org/W2019897525","https://openalex.org/W2023925005","https://openalex.org/W2024431507","https://openalex.org/W2024977477","https://openalex.org/W2032279605","https://openalex.org/W2034865298","https://openalex.org/W2041548571","https://openalex.org/W2041683554","https://openalex.org/W2047173091","https://openalex.org/W2052376299","https://openalex.org/W2055484034","https://openalex.org/W2057192508","https://openalex.org/W2058868308","https://openalex.org/W2065498565","https://openalex.org/W2068628534","https://openalex.org/W2074230792","https://openalex.org/W2078098282","https://openalex.org/W2080298074","https://openalex.org/W2081095794","https://openalex.org/W2091097539","https://openalex.org/W2093421851","https://openalex.org/W2093730240","https://openalex.org/W2111894013","https://openalex.org/W2117383601","https://openalex.org/W2120944960","https://openalex.org/W2126706827","https://openalex.org/W2126878602","https://openalex.org/W2132555220","https://openalex.org/W2133325736","https://openalex.org/W2138295167","https://openalex.org/W2143649406","https://openalex.org/W2152693824","https://openalex.org/W2155479770","https://openalex.org/W2158632654","https://openalex.org/W2159100845","https://openalex.org/W2160412284","https://openalex.org/W2163552968","https://openalex.org/W2327319870"],"related_works":["https://openalex.org/W2410050173","https://openalex.org/W2256324412","https://openalex.org/W2339207637","https://openalex.org/W4362460610","https://openalex.org/W3137697476","https://openalex.org/W1969412355","https://openalex.org/W2023925005","https://openalex.org/W4360977552","https://openalex.org/W3132273997","https://openalex.org/W2133325736"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"PURPOSE:":[2],"Insulin-like":[3],"growth":[4],"factor":[5],"I":[6],"(IGF-I)":[7],"exerts":[8],"neuroprotective":[9,36,50,119],"effects":[10],"in":[11,38,51,123,135],"both":[12],"white":[13],"and":[14,72,85,125,154,159,164],"gray":[15],"matter":[16],"under":[17],"different":[18,152,160],"detrimental":[19],"conditions.":[20],"The":[21],"purpose":[22],"of":[23,54,67,83,87,108,121,130,156,162],"this":[24],"review":[25],"is":[26,33],"to":[27,48,76,81,116,126],"collect":[28],"the":[29,63,88,106,118,128],"evidence":[30],"whether":[31],"IGF-I":[32,45,91,102,122,157,163],"a":[34],"candidate":[35],"drug":[37],"patients":[39],"with":[40],"acute":[41],"ischemic":[42],"stroke.":[43],"RESULTS:":[44],"was":[46],"found":[47,75],"be":[49,77,149],"animal":[52,137],"models":[53,138],"focal":[55],"brain":[56],"ischemia":[57],"when":[58],"given":[59],">or=2":[60],"hours":[61],"after":[62],"insult.":[64],"Different":[65],"routes":[66,155],"administration":[68,158],"(eg,":[69],"cerebroventricular,":[70],"intravenous,":[71],"intranasal)":[73],"were":[74],"effective.":[78],"In":[79],"addition":[80],"inhibition":[82],"apoptosis":[84],"reduction":[86],"infarct":[89],"volume,":[90],"also":[92,104],"improved":[93],"neurological":[94],"outcome.":[95],"Furthermore,":[96],"there":[97],"are":[98,114],"strong":[99],"indications":[100],"that":[101],"can":[103],"stimulate":[105],"regeneration":[107],"neural":[109],"tissue.":[110],"CONCLUSIONS:":[111],"Additional":[112],"studies":[113,134],"required":[115],"reveal":[117],"mechanisms":[120],"detail":[124],"elucidate":[127],"role":[129],"IGF-binding":[131,165],"proteins.":[132,166],"Preclinical":[133],"relevant":[136],"for":[139],"studying":[140],"stroke":[141],"(ie,":[142],"hypertensive,":[143],"diabetic,":[144],"or":[145],"aged":[146],"animals)":[147],"should":[148],"done":[150],"testing":[151],"doses":[153],"combinations":[161]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020947579","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
